Exagen (XGN)
Develops AVISE tests for diagnosis and monitoring of autoimmune disease.
$8.74
After hours−0.02 (−0.23%)
At close$8.76(+1.62%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.19
Revenue estimate
$18.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.20−$0.20−$0.18−$0.31−$0.20−$0.17−$0.13Pending
Estimate−$0.27−$0.20−$0.18−$0.16−$0.20−$0.24−$0.19−$0.19
Surprise+25.9%0.0%0.0%−97.6%0.0%+29.2%+32.1%—
RevenueReportedEstimate
Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$13.7M$15.5M$17.2M$17.2M$16.6M$17.3M$19.9MPending
Estimate$14.6M$14.6M$16.9M$16.9M$16.6M$16.4M$17.8M$18.3M
Surprise−6.3%+6.5%+1.8%+2.1%+0.4%+5.5%+12.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.11 | — | — |
| Sep 2027 | −$0.12 | — | — |
| Jun 2027 | −$0.11 | — | — |
| Mar 2027 | −$0.17 | — | — |
| Dec 2026 | −$0.19 | — | — |
| Nov 2026 | −$0.19 | — | — |
| Aug 2026 | −$0.19 | −$0.13 | +32.1% |
| May 2026 | −$0.24 | −$0.17 | +29.2% |
| Mar 2026 | −$0.20 | −$0.20 | 0.0% |
| Nov 2025 | −$0.16 | −$0.31 | −97.6% |
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Jun 2019 | |||
| Sep 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Mar 2015 | |||
| Dec 2014 | |||
| Sep 2014 | |||
| Jun 2014 | |||
| Mar 2014 | |||
| Dec 2013 | |||
| Sep 2013 | |||
| Jun 2013 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.11 | — | — | $20.7M | — | — | — |
| Sep 2027 | −$0.12 | — | — | $20.6M | — | — | — |
| Jun 2027 | −$0.11 | — | — | $21.2M | — | — | — |
| Mar 2027 | −$0.17 | — | — | $18.8M | — | — | — |
| Dec 2026 | −$0.19 | — | — | $18.3M | — | — | — |
| Nov 3, 2026 | −$0.19 | — | — | $18.3M | — | — | — |
| Aug 4, 2026 | −$0.19 | −$0.13 | +32.1% | $17.8M | $19.9M | +12.0% | +37.8% |
| May 11, 2026 | −$0.24 | −$0.17 | +29.2% | $16.4M | $17.3M | +5.5% | +34.9% |
| Mar 10, 2026 | −$0.20 | −$0.20 | 0.0% | $16.6M | $16.6M | +0.4% | −3.9% |
| Nov 4, 2025 | −$0.16 | −$0.31 | −97.6% | $16.9M | $17.2M | +2.1% | −9.0% |
| Jul 29, 2025 | |||||||
| May 5, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 18, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 20, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 22, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Jul 28, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 25, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Sep 20, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Mar 31, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Sep 30, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Mar 31, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Sep 30, 2013 | |||||||
| Jun 30, 2013 |